Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Xue F. Huang"'
Autor:
Guan Wang, Xi Kang, Katherine S. Chen, Tiffany Jehng, Lindsey Jones, Jie Chen, Xue F. Huang, Si-Yi Chen
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-14 (2020)
Oncolytic viruses can activate tumor neoantigen-specific T cell responses. However, PD-L1 upregulation on tumor cells and immune cells leads to tumor resistance to this immunotherapy approach. Here, the authors develop an oncolytic virus which expres
Externí odkaz:
https://doaj.org/article/a3a3521c2e584a13a47f5027ebb743e3
Autor:
Hongxiang Feng, Xiaowei Wang, Zhenrong Zhang, Chuanning Tang, Hua Ye, Lindsey Jones, Feng Lou, Dandan Zhang, Shouwen Jiang, Hong Sun, Haichao Dong, Guangchun Zhang, Zhiyuan Liu, Zhishou Dong, Baishuai Guo, He Yan, Chaowei Yan, Lu Wang, Ziyi Su, Yangyang Li, Vijayalakshmi Nandakumar, Xue F. Huang, Si-Yi Chen, Deruo Liu
Publikováno v:
Cancer Informatics, Vol 2015, Iss 14, Pp 83-93 (2015)
Externí odkaz:
https://doaj.org/article/51674100d9b34d7c9840fdc3de688de6
Autor:
Xue F. Huang, Gregory S. Shelness
Publikováno v:
Journal of Lipid Research, Vol 40, Iss 12, Pp 2212-2222 (1999)
The balance between the hepatic assembly of apolipoprotein B (apoB) and its presecretory degradation at the level of the endoplasmic reticulum (ER) may control the secretion of apoB-containing lipoproteins. In one model, apoB that fails to assemble w
Externí odkaz:
https://doaj.org/article/1a70aa48d3d14ac1aaa2f128ead0ea06
Supplementary Figure Legends 1-4 from Human Suppressor of Cytokine Signaling 1 Controls Immunostimulatory Activity of Monocyte-Derived Dendritic Cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dec04d2807a6694d96c5d29628ed18c6
https://doi.org/10.1158/0008-5472.22382685.v1
https://doi.org/10.1158/0008-5472.22382685.v1
Supplementary Figure 4 from Human Suppressor of Cytokine Signaling 1 Controls Immunostimulatory Activity of Monocyte-Derived Dendritic Cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5efc1ca4d7d6404ad9924aa894e75fd2
https://doi.org/10.1158/0008-5472.22382688
https://doi.org/10.1158/0008-5472.22382688
Supplementary Figure 3 from Human Suppressor of Cytokine Signaling 1 Controls Immunostimulatory Activity of Monocyte-Derived Dendritic Cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fb3ebb93a2a17a32ec9dd952d69a312
https://doi.org/10.1158/0008-5472.22382691
https://doi.org/10.1158/0008-5472.22382691
Supplementary Figure 1 from Human Suppressor of Cytokine Signaling 1 Controls Immunostimulatory Activity of Monocyte-Derived Dendritic Cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::231b615a30e919b2873f0c1bedfefaae
https://doi.org/10.1158/0008-5472.22382697.v1
https://doi.org/10.1158/0008-5472.22382697.v1
Dendritic cell (DC)–based tumor vaccines have only achieved limited clinical efficacy, underscoring the limitation of stimulatory strategies to elicit effective cytotoxic T lymphocyte (CTL) responses against self-tumor–associated antigens. Here,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::03f1c59c390c97dc9104edea33ad31f0
https://doi.org/10.1158/0008-5472.c.6500289
https://doi.org/10.1158/0008-5472.c.6500289
Supplementary Figure 2 from Human Suppressor of Cytokine Signaling 1 Controls Immunostimulatory Activity of Monocyte-Derived Dendritic Cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23990569ec6811a9a878fbb201397930
https://doi.org/10.1158/0008-5472.22382694
https://doi.org/10.1158/0008-5472.22382694
Autor:
Katherine S. Chen, Xi Kang, Xue F. Huang, Tiffany Jehng, Si-Yi Chen, Jie Chen, Lindsey Jones, Guan Wang
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-14 (2020)
Nature Communications
Nature Communications
Oncolytic viruses offer an in situ vaccination approach to activate tumor-specific T cell responses. However, the upregulation of PD-L1 expression on tumor cells and immune cells leads to tumor resistance to oncolytic immunotherapy. In this study, we